Status:
NOT_YET_RECRUITING
Theoretically Informed Behavioral Intervention
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
HIV
CVD
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The goal of this waitlist control clinical trial is to learn if the tailored LEARN 2 platform can prevent HIV-related comorbidities with shared risk factors in men ages 18 and older living with HIV. T...
Detailed Description
The goal of this waitlist control clinical trial is to determine the efficacy of the tailored LEARN 2 platform in preventing HIV-related comorbidities characterized by shared risk factors. The princip...
Eligibility Criteria
Inclusion
- Self-identify as:
- living with HIV
- English speaking
- Access to a device compatible with LEARN 2
Exclusion
- \- medical history of serious complications such as heart attack, stroke, cognitive impairment, or cancer.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2029
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT06580184
Start Date
January 1 2026
End Date
March 31 2029
Last Update
July 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
Orange, Connecticut, United States, 06477